Study | Representativeness of participants | Selection of nonexposed cohort | Ascertainment of exposure | Outcome not present | Comparability of controls | Assessment of outcome | Adequate follow-up | Loss to follow-up | Total score |
---|---|---|---|---|---|---|---|---|---|
Kluger et al. (8) | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
Jacobs et al. (9) | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
Jacobs et al. (10) | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
Gaarder et al. (11) | Truly representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
King et al. (13) | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
Tugnoli et al. (14) | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
Sohn et al. (15) | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
Sohn et al. (16) | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
Rubiano et al. (17) | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
McLaughlin et al. (19) | Somewhat representative* | No control group | Prospective cohort* | Yes* | No control | Prospective cohort* | Yes* | None reported* | 6/9 |
Refer to Wells et al. (6) for a description of Newcastle–Ottawa Quality Assessment Scale for cohort studies. In general, more stars denote higher quality. Representativeness is awarded a star if the cohort is truly or somewhat representative of the population of interest. For selection of the nonexposed cohort, a star is awarded if it is drawn from the same population as the exposed cohort. The relevant exposure in this review is the surgical procedure performed in the live tissue; we considered a nonexposed cohort to be one that performed the procedure in another simulation method. Exposure is satisfactorily ascertained if data are collected from a secure record. A star is awarded if the outcome is not present at the start of the study. A maximum of 2 stars can be given for comparability of controls for controlling of confounders in either the design (matching) or analysis (statistical adjustment) phase. We also gave 1 star when selection criteria appeared to create comparable groups via restriction. Assessment of outcome is awarded a star if the outcomes were assessed by independent blind assessment or record linkage. The duration of follow-up was considered adequate if it was long enough for the outcomes to occur. Completeness of follow-up was considered adequate if all participants were accounted for or if the number lost to follow-up was sufficiently low to be unlikely to introduce bias.